As a pivotal player in the technology and innovation ecosystem, Desjardins Caisse Des Technologies is thrilled to recognize one of our esteemed members, NeuroServo, for successfully closing a $2.2M CAD funding round. This remarkable achievement will empower NeuroServo to amplify the reach of their groundbreaking medical device, VEEGix, designed for instant brain wave analysis in crucial medical environments. We take immense pride in witnessing our members achieve such milestones and continue to drive forward Québec’s reputation for tech innovation.
For a comprehensive insight into NeuroServo’s journey and the specifics of their latest round of funding, delve into the original press release here.
